McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
Read More…
Industry, Sector and Symbol
Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
Phone972-446-4800
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$214.32 billion
Profitability
Miscellaneous
Employees80,000
Next Earnings Date10/24/2019 (Estimated)
OptionableOptionable
McKesson (NYSE:MCK) Frequently Asked Questions
What is McKesson's stock symbol?
McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."
How often does McKesson pay dividends? What is the dividend yield for McKesson?
McKesson announced a quarterly dividend on Wednesday, July 31st. Investors of record on Tuesday, September 3rd will be paid a dividend of $0.41 per share on Tuesday, October 1st. This represents a $1.64 annualized dividend and a yield of 1.13%. The ex-dividend date is Friday, August 30th. This is a positive change from McKesson's previous quarterly dividend of $0.39. View McKesson's Dividend History.
How were McKesson's earnings last quarter?
McKesson Co. (NYSE:MCK) announced its quarterly earnings data on Wednesday, July, 31st. The company reported $3.31 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $3.04 by $0.27. The firm earned $55.73 billion during the quarter, compared to analysts' expectations of $54.03 billion. McKesson had a net margin of 0.27% and a return on equity of 30.73%. The business's revenue for the quarter was up 5.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.90 EPS. View McKesson's Earnings History.
When is McKesson's next earnings date?
What guidance has McKesson issued on next quarter's earnings?
McKesson issued an update on its FY20 earnings guidance on Wednesday, July, 31st. The company provided earnings per share guidance of $14.00-14.60 for the period, compared to the Thomson Reuters consensus EPS estimate of $14.12.
What price target have analysts set for MCK?
9 analysts have issued 12-month target prices for McKesson's shares. Their forecasts range from $130.00 to $175.00. On average, they expect McKesson's stock price to reach $149.2222 in the next year. This suggests a possible upside of 2.7% from the stock's current price. View Analyst Price Targets for McKesson.
What is the consensus analysts' recommendation for McKesson?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 7 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for McKesson.
Has McKesson been receiving favorable news coverage?
Media coverage about MCK stock has trended negative recently, according to InfoTrie. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. McKesson earned a media sentiment score of -2.3 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for McKesson.
Are investors shorting McKesson?
McKesson saw a increase in short interest during the month of July. As of July 15th, there was short interest totalling 4,773,500 shares, an increase of 8.4% from the June 15th total of 4,401,900 shares. Based on an average daily trading volume, of 1,360,000 shares, the days-to-cover ratio is currently 3.5 days. Approximately 2.5% of the shares of the stock are sold short. View McKesson's Current Options Chain.
Who are some of McKesson's key competitors?
What other stocks do shareholders of McKesson own?
Who are McKesson's key executives?
McKesson's management team includes the folowing people:
- Mr. John H. Hammergren, Chairman & CEO (Age 60)
- Britt J. Vitalone, CFO & Exec. VP (Age 50)
- Ms. Lori A. Schechter, Chief Compliance Officer, Exec. VP & Gen. Counsel (Age 57)
- Mr. Jorge L. Figueredo, Exec. VP & Chief HR Officer (Age 58)
- Mr. Bansi Nagji, Exec. VP and Chief Strategy & Bus. Devel. Officer (Age 54)
Who are McKesson's major shareholders?
McKesson's stock is owned by a number of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (8.70%), BlackRock Inc. (8.16%), Invesco Ltd. (2.98%), Pzena Investment Management LLC (2.07%), Baupost Group LLC MA (1.40%) and Northern Trust Corp (1.32%). Company insiders that own McKesson stock include Brian Scott Tyler, Britt J Vitalone, Erin M Lampert, John H Hammergren, Lori A Schechter, M Christine Jacobs and N Anthony Coles. View Institutional Ownership Trends for McKesson.
Which institutional investors are selling McKesson stock?
MCK stock was sold by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, UBS Group AG, Van ECK Associates Corp, Baupost Group LLC MA, Ruffer LLP, Renaissance Technologies LLC, Quest Capital Management Inc. ADV and Vanguard Group Inc.. Company insiders that have sold McKesson company stock in the last year include Brian Scott Tyler, Britt J Vitalone, Lori A Schechter, M Christine Jacobs and N Anthony Coles. View Insider Buying and Selling for McKesson.
Which institutional investors are buying McKesson stock?
MCK stock was purchased by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Royal Bank of Canada, BlackRock Inc., APG Asset Management N.V., Pzena Investment Management LLC, Price T Rowe Associates Inc. MD, Tavio Capital LLC and Man Group plc. View Insider Buying and Selling for McKesson.
How do I buy shares of McKesson?
Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is McKesson's stock price today?
One share of MCK stock can currently be purchased for approximately $145.29.
How big of a company is McKesson?
McKesson has a market capitalization of $26.86 billion and generates $214.32 billion in revenue each year. The company earns $34 million in net income (profit) each year or $13.57 on an earnings per share basis. McKesson employs 80,000 workers across the globe.View Additional Information About McKesson.
What is McKesson's official website?
How can I contact McKesson?
McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at 972-446-4800 or via email at [email protected]
MarketBeat Community Rating for McKesson (NYSE MCK)
MarketBeat's community ratings are surveys of what our community members think about McKesson and other stocks. Vote "Outperform" if you believe MCK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MCK will underperform the S&P 500 over the long term. You may vote once every thirty days.
